tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZYME Stock Latest News

Oracle initiated, Uber upgraded: Wall Street’s top analyst calls
The FlyOracle initiated, Uber upgraded: Wall Street’s top analyst calls
3d ago
W
WEN
Zymeworks initiated with an Outperform at Citizens JMP
PremiumThe Fly
Zymeworks initiated with an Outperform at Citizens JMP
3d ago
ZYME
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences
PremiumCompany Announcements
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences
4d ago
ZYME
Zymeworks to Engage in Key Investor Conferences
PremiumCompany Announcements
Zymeworks to Engage in Key Investor Conferences
12d ago
ZYME
3 Best Stocks to Buy Now, According to Top Analysts, 11/24/2025
PremiumMarket News
3 Best Stocks to Buy Now, According to Top Analysts, 11/24/2025
12d ago
DDOG
HIVE
Zymeworks price target raised to $40 from $30 at B. Riley
PremiumThe FlyZymeworks price target raised to $40 from $30 at B. Riley
15d ago
ZYME
Zymeworks price target raised to $40 from $37 at Leerink
Premium
The Fly
Zymeworks price target raised to $40 from $37 at Leerink
17d ago
ZYME
Zymeworks price target raised to $25 from $17 at Wells Fargo
Premium
The Fly
Zymeworks price target raised to $25 from $17 at Wells Fargo
17d ago
ZYME
Zymeworks price target raised to $40 from $30 at Stifel
PremiumThe Fly
Zymeworks price target raised to $40 from $30 at Stifel
17d ago
JAZZ
ZYME
Zymeworks’ Promising Phase 3 Results Drive Buy Rating for HER2-Positive Cancer Treatment
PremiumRatings
Zymeworks’ Promising Phase 3 Results Drive Buy Rating for HER2-Positive Cancer Treatment
18d ago
ZYME
Zymeworks Appoints Scott Platshon as Acting CIO
PremiumCompany Announcements
Zymeworks Appoints Scott Platshon as Acting CIO
18d ago
8K
ZYME
Zymeworks price target raised to $32 from $26 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $32 from $26 at H.C. Wainwright
18d ago
ZYME
Zymeworks announces new $125M share repurchase plan
PremiumThe FlyZymeworks announces new $125M share repurchase plan
18d ago
ZYME
Zymeworks announces strategic initiative to optimize Ziihera cash flows
Premium
The Fly
Zymeworks announces strategic initiative to optimize Ziihera cash flows
18d ago
JNJ
ZYME
Zymeworks appoints Scott Platshon as acting chief investment officer
Premium
The Fly
Zymeworks appoints Scott Platshon as acting chief investment officer
18d ago
ZYME
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
PremiumMarket News
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
18d ago
ONC
JAZZ
Zymeworks Stock Upgraded to ‘Buy’ on Promising Phase 3 Trial Results and Financial Prospects
PremiumRatings
Zymeworks Stock Upgraded to ‘Buy’ on Promising Phase 3 Trial Results and Financial Prospects
19d ago
ZYME
Zymeworks price target raised to $42 from $30 at Jefferies
PremiumThe Fly
Zymeworks price target raised to $42 from $30 at Jefferies
19d ago
ZYME
Zymeworks price target raised to $37 from $24 at Leerink
PremiumThe Fly
Zymeworks price target raised to $37 from $24 at Leerink
19d ago
ZYME
Zymeworks’ Promising Clinical Trial Results and Market Potential Justify Buy Rating
PremiumRatingsZymeworks’ Promising Clinical Trial Results and Market Potential Justify Buy Rating
19d ago
ZYME
Zymeworks price target raised to $35 from $22 at Citi
Premium
The Fly
Zymeworks price target raised to $35 from $22 at Citi
19d ago
ZYME
Midday Fly By: Berkshire takes Alphabet stake, J&J buying cancer drug maker
Premium
The Fly
Midday Fly By: Berkshire takes Alphabet stake, J&J buying cancer drug maker
19d ago
BA
EYE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >